107
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Monitoring local delivery of vancomycin from gelatin nanospheres in zebrafish larvae

, , , , , , , , & show all
Pages 5377-5394 | Published online: 13 Sep 2018

References

  • GarzoniCKelleyWLStaphylococcus aureus: new evidence for intracellular persistenceTrends Microbiol2009172596519208480
  • TongSYDavisJSEichenbergerEHollandTLFowlerVGJrStaphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and managementClin Microbiol Rev201528360366126016486
  • MoriartyTFKuehlRCoenyeTOrthopaedic device-related infection: current and future interventions for improved prevention and treatmentEFORT Open Rev201614899928461934
  • EllingtonJKHarrisMHudsonMCVishinSWebbLXSherertzRIntracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitisJ Orthop Res2006241879316419973
  • RioolMde BoerLJaspersVStaphylococcus epidermidis originating from titanium implants infects surrounding tissue and immune cellsActa Biomater201410125202521225153780
  • BoelensJJDankertJMurkJLBiomaterial-associated persistence of Streptococcus epidermidis in pericatheter macrophagesJ Infect Dis200018141337134910762565
  • BroekhuizenCANde BoerLSchipperKStaphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatmentJ Biomed Mater Res A200885A2498505
  • ZaatSAJBroekhuizenCANRioolMHost tissue as a niche for biomaterial-associated infectionFuture Microbiol2010581149115120722591
  • Barcia-MacayMSeralCMingeot-LeclercqMPTulkensPMVan BambekeFPharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophagesAntimicrob Agents Chemother200650384185116495241
  • CarrynSVan BambekeFMingeot-LeclereqMPTulkensPMComparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrationsAntimicrob Agents Chemother20024672095210312069960
  • AbedNCouvreurPNanocarriers for antibiotics: a promising solution to treat intracellular bacterial infectionsInt J Antimicrob Agents201443648549624721232
  • XiongMHBaoYYangXZZhuYHWangJDelivery of antibiotics with polymeric particlesAdv Drug Delivery Rev2014786376
  • RuszczakZFriessWCollagen as a carrier for on-site delivery of antibacterial drugsAdv Drug Delivery Rev2003551216791698
  • UengSWLeeMSLinSSChanECLiuSJDevelopment of a biodegradable alginate carrier system for antibiotics and bone cellsJ Orthop Res2007251627217019681
  • LecarozMCBlanco-PrietoMJCampaneroMASalmanHGamazoCPoly(d,l-lactide-coglycolide) particles containing gentamicin: pharma-cokinetics and pharmacodynamics in Brucella melitensis-infected miceAntimicrob Agents Chemother20075141185119017220415
  • KhalilIRBurnsATRadeckaIBacterial-derived polymer poly-y-glutamic acid (y-PGA)-based micro/nanoparticles as a delivery system for antimicrobials and other biomedical applicationsInt J Mol Sci2017182 pii:E313
  • LiuHSlamovichEBWebsterTJLess harmful acidic degradation of poly(lacticcoglycolic acid) bone tissue engineering scaffolds through titania nanoparticle additionInt J Nanomedicine20061454154517722285
  • SantoroMTataraAMMikosAGGelatin carriers for drug and cell delivery in tissue engineeringJ Control Release201419021021824746627
  • SongJLeeuwenburghSCSustained delivery of biomolecules from gelatin carriers for applications in bone regenerationTher Deliv20145894395825337650
  • FooxMZilbermanMDrug delivery from gelatin-based systemsExpert Opin Drug Deliv20151291547156325943722
  • SuKWangCRecent advances in the use of gelatin in biomedical researchBiotechnol Lett201537112139214526160110
  • WangHBoermanOCSariibrahimogluKLiYJansenJALeeuwenburghSCComparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphataseBiomaterials201233338695870322922022
  • van der StokJWangHAmin YavariSEnhanced bone regeneration of cortical segmental bone defects using porous titanium scaffolds incorporated with colloidal gelatin gels for time- and dose-controlled delivery of dual growth factorsTissue Eng Part A20131923–242605261423822814
  • WangHZouQBoermanOCCombined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivoJ Control Release2013166217218123266450
  • DoiNJoJITabataYPreparation of biodegradable gelatin nanospheres with a narrow size distribution for carrier of cellular internalization of plasmid DNAJ Biomater Sci Polym Ed2012238991100421477460
  • IshikawaHNakamuraYJoJTabataYGelatin nanospheres incorporating siRNA for controlled intracellular releaseBiomaterials201233359097910422985993
  • SongJKOdekerkenJCELowikDWPMInfluence of the molecular weight and charge of antibiotics on their release kinetics from gelatin nanospheresMacromol Biosci201515790191125771899
  • SongJChenQZhangYElectrophoretic deposition of chitosan coatings modified with gelatin nanospheres to tune the release of antibioticsACS Appl Mater Interfaces2016822137851379227167424
  • SongJKlymovAShaoJElectrospun nanofibrous silk fibroin membranes containing gelatin nanospheres for controlled delivery of biomoleculesAdv Healthc Mater2017614110
  • WangHHansenMBLowikDWOppositely charged gelatin nanospheres as building blocks for injectable and biodegradable gelsAdv Mater20112312H119H12421394793
  • NaharMDubeyVMishraDMishraPKDubeAJainNKIn vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasisJ Drug Target20101829310519640212
  • VenemanWJMarin-JuezRde SonnevilleJEstablishment and optimization of a high throughput setup to study Staphylococcus epidermidis and Mycobacterium marinum infection as a model for drug discoveryJ Vis Exp201488e5164924998295
  • PrajsnarTKCunliffeVTFosterSJRenshawSAA novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogensCell Microbiol200810112312232518715285
  • FenaroliFWestmorelandDBenjaminsenJNanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatmentACS Nano2014877014702624945994
  • SharifFPortaFMeijerAHKrosARichardsonMKMesoporous silica nanoparticles as a compound delivery system in zebrafish embryosInt J Nanomedicine201271875189022605936
  • StrahleUScholzSGeislerRZebrafish embryos as an alternative to animal experiments – a commentary on the definition of the onset of protected life stages in animal welfare regulationsReprod Toxicol201233212813221726626
  • RenshawSATredeNSA model 450 million years in the making: zebrafish and vertebrate immunityDis Model Mech201251384722228790
  • GoldsmithPZebrafish as a pharmacological tool: the how, why and whenCurr Opin Pharmacol20044550451215351356
  • DelvecchioCTiefenbachJKrauseHMThe zebrafish: a powerful platform for in vivo, HTS drug discoveryAssay Drug Dev Technol20119435436121309713
  • ZhangXStockhammerOWde BoerLThe zebrafish embryo as a model to quantify early inflammatory cell responses to biomaterialsJ Biomed Mater Res A201710592522253228509403
  • SurewaardBGJDenisetJFZempFJIdentification and treatment of the Staphylococcus aureus reservoir in vivoJ Exp Med201621371141115127325887
  • BrandMGrantoMKeeping and raising zebrafishNüsslein-VolhardCDahmRZebrafish, A Practical ApproachOxfordOxford University Press2002737
  • SongJNanostructured carriers for the delivery of antibacterial agentsPhD thesisDepartment of Biomaterials, Radboud University Nijmegen2016
  • GrayCLoynesCAWhyteMKBCrossmanDCRenshawSAChicoTJASimultaneous intravital imaging of macrophage and neutro-phil behaviour during inflammation using a novel transgenic zebrafishThromb Haemost2011105581181921225092
  • EllettFPaseLHaymanJWAndrianopoulosALieschkeGJmpeg1 promoter transgenes direct macrophage-lineage expression in zebrafishBlood20111174E49E5621084707
  • BenardELvan der SarAMEllettFLieschkeGJSpainkHPMeijerAHInfection of zebrafish embryos with intracellular bacterial pathogensJ Vis Exp201261e3781
  • AndoRHamaHYamamoto-HinoMMizunoHMiyawakiAAn optical marker based on the UV-induced green-to-red photoconversion of a fluorescent proteinProc Natl Acad Sci U S A20029920126511265612271129
  • LombardoVASporbertAAbdelilah-SeyfriedSCell tracking using photoconvertible proteins during zebrafish developmentJ Vis Exp201267e4350
  • RioolMDirksAJJaspersVA chlorhexidine-releasing epoxy-based coating on titanium implants prevents Staphylococcus aureus experimental biomaterial-associated infectionEur Cell Mater20173314315728197990
  • GordonSThe macrophage: past, present and futureEur J Immunol200737S9S1717972350
  • OhNParkJHEndocytosis and exocytosis of nanoparticles in mammalian cellsInt J Nanomedicine20149516324872703
  • SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
  • PrajsnarTKHamiltonRGarcia-LaraJA privileged intraphagocyte niche is responsible for disseminated infection of Staphylococcus aureus in a zebrafish modelCell Microbiol201214101600161922694745
  • GroszMKolterJPaprotkaKCytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alphaCell Microbiol201416445146524164701
  • GarciaLGLemaireSKahlBCAntibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical dataJ Antimicrob Chemother20136871455146423485724
  • RussellDGMycobacterium tuberculosis: here today, and here tomorrowNat Rev Mol Cell Biol20012856957711483990